{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:18:01Z","timestamp":1781342281608,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Provincial Engineering Center For Major Neurological Disease Treatment","award":["Guangdong Provincial Engineering Center For Major Neurological Disease Treatment"],"award-info":[{"award-number":["Guangdong Provincial Engineering Center For Major Neurological Disease Treatment"]}]},{"DOI":"10.13039\/100016101","name":"Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease","doi-asserted-by":"publisher","award":["Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease"],"award-info":[{"award-number":["Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease"]}],"id":[{"id":"10.13039\/100016101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10072-024-07728-w","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:02:29Z","timestamp":1724828549000},"page":"5909-5913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics and therapeutic effect of myasthenia gravis coexisting with thyroid eye disease"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6934-3253","authenticated-orcid":false,"given":"Yin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"7728_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.553626","volume":"11","author":"P Szczudlik","year":"2020","unstructured":"Szczudlik P, Sobieszczuk E, Szyluk B et al (2020) Determinants of quality of life in myasthenia\u2002gravis\u2002patients. Front Neurol 11:1\u20137","journal-title":"Front Neurol"},{"issue":"10","key":"7728_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023\u20131036","journal-title":"Lancet Neurol"},{"issue":"9","key":"7728_CR3","first-page":"e10248","volume":"129","author":"S Amin","year":"2020","unstructured":"Amin S, Aung M, Gandhi FR et al (2020) Myasthenia\u2002gravis and its association with\u2002thyroid\u2002diseases. Cureus 129(9):e10248","journal-title":"Cureus"},{"key":"7728_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000279334","volume":"34","author":"A McGrogan","year":"2010","unstructured":"McGrogan A, Sneddon S, de Vries CS (2010) The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiol 34:171\u2013183","journal-title":"Neuroepidemiol"},{"issue":"10","key":"7728_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2019.102368","volume":"18","author":"RH Song","year":"2019","unstructured":"Song RH, Yao QM, Wang B et al (2019) Thyroid disorders in patients with myasthenia gravis: a systematic review and meta-analysis. Autoimmun Rev 18(10):1\u20138","journal-title":"Autoimmun Rev"},{"issue":"3","key":"7728_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/IIO.0000000000000277","volume":"59","author":"KD Bojikian","year":"2009","unstructured":"Bojikian KD, Francis CE (2009) Thyroid\u2002eye\u2002disease\u2002and\u2002myasthenia\u2002gravis. Int Ophthalmol Clin 59(3):113\u2013124","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"7728_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12883-020-02022-6","volume":"20","author":"J Tang","year":"2020","unstructured":"Tang J, Qin C (2020) Rare concurrent ocular\u2002myasthenia\u2002gravis\u2002and Graves\u2019 ophthalmopathy in a man with Poland syndrome: a case report. BMC Neurol 20(1):444\u2013448","journal-title":"BMC Neurol"},{"issue":"1","key":"7728_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12886-020-01431-y","volume":"20","author":"R Ma","year":"2020","unstructured":"Ma R, Cheng Y, Gan L et al (2020) Histopathologic study of extraocular muscles in\u2002thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report. BMC Ophthalmol 20(1):166\u2013171","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"7728_CR9","first-page":"266","volume":"46","author":"K Maeda","year":"2006","unstructured":"Maeda K, Kume S, Nishio Y et al (2006) Severe Graves\u2019 ophthalmopathy accompanied by\u2002myasthenia\u2002gravis. Rinsho Shinkeigaku 46(4):266\u2013269","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"7728_CR10","first-page":"0","volume":"37","author":"Y Hong-Wei","year":"2017","unstructured":"Hong-Wei Y, Ying-Xue W, Jie, Bao et al (2017) Correlation of HLA-DQ and TNF-\u03b1 gene polymorphisms with ocular myasthenia gravis combined with thyroid-associated ophthalmopathy. Biosci Rep 37(2):0","journal-title":"Biosci Rep"},{"issue":"10","key":"7728_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5694\/j.1326-5377.2004.tb06066.x","volume":"180","author":"MS Parmar","year":"2004","unstructured":"Parmar MS (2004) Diagnosis and management\u2002of\u2002hyperthyroidism and hypothyroidism. Med J Aust 180(10):542","journal-title":"Med J Aust"},{"issue":"6","key":"7728_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","volume":"119","author":"GB Bartley","year":"1995","unstructured":"Bartley GB, Gorman CA (1995) Diagnostic\u2002criteria\u2002for Graves\u2019 ophthalmopathy. Am J Ophthalmol 119(6):792\u2013795","journal-title":"Am J Ophthalmol"},{"key":"7728_CR13","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1002\/brb3.537","volume":"6","author":"J Kubiszewska","year":"2016","unstructured":"Kubiszewska J, Szyluk B, Szczudlik P et al (2016) Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain Behav 6:e00537","journal-title":"Brain Behav"},{"key":"7728_CR14","doi-asserted-by":"crossref","unstructured":"Wang Y, Qi G, Yang Y(2022)analysis of clinical features of myasthenia gravis complicated with hyperthyroidism. Pak J Med Sci 38:530\u2013535","DOI":"10.12669\/pjms.38.3.4656"},{"issue":"5","key":"7728_CR15","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1210\/en.2018-01048","volume":"1605","author":"R Latif","year":"2019","unstructured":"Latif R, Mezei M, Morshed SA et al (2019) A modifying autoantigen in Graves\u2019 disease. Endocrinology 1605(5):1008\u20131020","journal-title":"Endocrinology"},{"issue":"3","key":"7728_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3349\/ymj.2016.57.3.795","volume":"57","author":"Y Song","year":"2016","unstructured":"Song Y, Shin W, Jae-Kyung KM, Jeong et al (2016) Graves\u2019 patient with thymic expression of Thyrotropin receptors and dynamic changes in Thymic Hyperplasia Proportional to Graves\u2019 Disease Activity. Yonsei Med J 57(3):795\u2013798","journal-title":"Yonsei Med J"},{"issue":"8","key":"7728_CR17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1089\/thy.2017.0086","volume":"27","author":"R Haider Uzma","year":"2017","unstructured":"Haider Uzma R, Patrick, Gianoukakis Andrew G (2017) Thymic Hyperplasia Associated with Graves\u2019 Disease: pathophysiology and proposed management algorithm. Thyroid 27(8):994\u20131000","journal-title":"Thyroid"},{"key":"7728_CR18","first-page":"18","volume":"2019","author":"C Kamath","year":"2019","unstructured":"Kamath C, Witczak J, Adlan MA, Premawardhana LD (2019) Managing thymic enlargement in Graves\u2019 disease. Endocrinol Diabetes Metab Case Rep 2019:18\u20130119","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"7728_CR19","doi-asserted-by":"crossref","unstructured":"Eng L, Underland L, Lam L (2019) Intrathyroidal thymic tissue in an adolescent with Graves\u2019 disease: case report and review of current literature. Case Rep Pediatr 2019:1-4","DOI":"10.1155\/2019\/8089714"},{"issue":"3","key":"7728_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.amjmed.2019.07.051","volume":"133","author":"M Voss","year":"2020","unstructured":"Voss M, Saeed ZI, Donegan D (2020) Not a grave finding:\u2002thymic hyperplasia in the setting of Graves\u2019\u2002disease. Am J Med 133(3):308\u2013310","journal-title":"Am J Med"},{"key":"7728_CR21","doi-asserted-by":"crossref","unstructured":"Chen YL, Yeh JH Chiu HC(2013)clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan. Acta Neurol Scand 127:170\u2013174","DOI":"10.1111\/j.1600-0404.2012.01693.x"},{"key":"7728_CR22","doi-asserted-by":"crossref","unstructured":"Nacu A, Andersen JB, Lisnic V et Al(2015)complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 48:362\u2013368","DOI":"10.3109\/08916934.2015.1030614"},{"issue":"5","key":"7728_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/mus.27118","volume":"63","author":"B Claytor","year":"2021","unstructured":"Claytor B, Li Y (2021) Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Muscle Nerve 63(5):631\u2013639","journal-title":"Muscle Nerve"},{"key":"7728_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4158\/EP.7.4.275","volume":"7","author":"LK Tanwani","year":"2001","unstructured":"Tanwani LK, Lohano V, Ewart R et al (2001) Myasthenia gravis in conjunction with Graves\u2019 disease: a diagnostic challenge. Endocr Pract 7:275\u2013278","journal-title":"Endocr Pract"},{"issue":"3","key":"7728_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/IIO.0000000000000277","volume":"593","author":"KD Bojikian","year":"2019","unstructured":"Bojikian KD, Francis CE (2019) Thyroid eye disease and myasthenia gravis. Int Ophthalmol Clin 593(3):113\u2013124","journal-title":"Int Ophthalmol Clin"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07728-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07728-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07728-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T10:10:42Z","timestamp":1731319842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07728-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["7728"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07728-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"9 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board approval of our hospital was obtained for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients involved in this study gave their informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}